Scarica l'app Stockscreener
116.19
0.11%
-0.1912
Icon Plc Borsa (ICLR) Ultime notizie
Icon (ICLR) Receives Sector Perform Rating from RBC Capital - GuruFocus
ICON expands US early phase research capabilities with new clinic and outpatient centres - MSN
ICON plc stock (IE0005711209): clinical research specialist after solid Q1 update - AD HOC NEWS
ICLR SEC FilingsICON PLC 10-K, 10-Q, 8-K Forms - Stock Titan
ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fra - GuruFocus
Harris Associates L.P. discloses 5.7% stake in ICON plc (ICLR) - Stock Titan
Orbis, Allan Gray file Schedule 13G/A for ICON PLC (ICLR) reporting 0 shares - Stock Titan
Hybrid Clinical Research Job at ICON | Life Science Graduates Must Apply! - BioTecNika
ICON PLC (NASDAQ: ICLR) director logs 5,005-option expiration extension - Stock Titan
ICON PLC (ICLR) director logs mixed transactions on 5,005 stock options - Stock Titan
ICON PLC (ICLR) director reshapes 3,255 stock options in Form 4 - Stock Titan
Wellington entities report 7.74% stake in Icon (ICLR) - Stock Titan
Icon Opens New Clinical Facilities in Move to Expand Early-Phase Capabilities - Moomoo
ICON plc stock (IE0005711209): Expands early-phase research with new Texas clinic - AD HOC NEWS
ICON opens new Texas clinical research unit - BioXconomy
ICON (ICLR) Expands Early Phase Capabilities with New Facilities - GuruFocus
A Look at Icon PLC (ICLR) After 3.7% Decline -- GF Value $241.78 vs Price $117.38 - GuruFocus
Icon announces new Clinical Research Unit in San Antonio, Texas - TipRanks
Icon Expands Early Phase Capabilities - Contract Pharma
ICON's New Texas Hub Aims to Reshape Early Phase Drug Trials - BriefGlance
Hybrid Clinical Research Associate Job at ICON plc | Apply Now - BioTecNika
Templeton Growth Fund, Inc.'s Icon PLC(ICLR) Holding History - GuruFocus
Does ICON (ICLR)ʼs 20‑F Delay Reshape the Narrative Around Its Strong Institutional Ownership Base? - Sahm
A Look at Icon PLC (ICLR) After 4.7% Decline -- GF Value $241.81 vs Price $118.96 - GuruFocus
Icon Plc $ICLR Shares Sold by Truist Financial Corp - MarketBeat
ICON earnings on deck: Can CRO move past accounting cloud? - Investing.com UK
ICON plc Delays Annual 20-F Amid Restatement - TipRanks
Invesco Ltd. takes 5.1% stake in ICON PLC (ICLR) via 3.88M shares - Stock Titan
FMR LLC discloses 4,174,005.50 shares in ICON PLC (ICLR) on Schedule 13G - Stock Titan
HealthVerity to acquire data platform Symphony Health - MobiHealthNews
Principal Financial Group Inc. Cuts Stock Position in Icon Plc $ICLR - MarketBeat
MSN Money - msn.com
Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $125 - Moomoo
Icon Plc $ICLR Position Trimmed by Kornitzer Capital Management Inc. KS - MarketBeat
ICON (ICLR) Delays 20-F for Multi-Year Revenue Restatements Is Governance Now the Key Risk? - simplywall.st
Icon PLC | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F - Moomoo
Is Icon PLC (ICLR) a Bargain After 4.8% Drop? GF Value Says Unde - GuruFocus
Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating, Announces Target Price $139 - 富途牛牛
ICLR Price Today: Icon Plc Stock Price, Quote & Chart | MEXC - MEXC Exchange
William Blair Maintains Icon PLC(ICLR.US) With Buy Rating - Moomoo
What Just Happened at ICON (ICLR) and Why Did Shares Soar - Kavout
Jennison Associates LLC Makes New $123.54 Million Investment in Icon Plc $ICLR - MarketBeat
Truist reiterates Hold rating on ICON stock, $139 price target - Investing.com UK
Truist reiterates Hold rating on ICON stock, $139 price target By Investing.com - Investing.com India
ICON to Restate 2023–2025 Results After Audit Flags Revenue Recognition Issues - The Globe and Mail
Is It Too Late to Buy Icon PLC (ICLR) After 13.3% Rally? GF Value Says Undervalued - GuruFocus
Icon Clears the Air: Accounting Adjustments Prove Less Severe Than Feared - AD HOC NEWS
ICLR Stock Holds Support As Traders Watch Next Move - StocksToTrade
ICLR Stock Climbs As Support Holds And Value Case Builds - timothysykes.com
1.19%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):